Form 4: Ionis Pharmaceuticals Executive Richard S. Geary Reports Stock Transactions

Richard S. Geary, EVP and Chief Development Officer of Ionis Pharmaceuticals, reports acquisition of shares through vesting of performance-based restricted stock units and subsequent sale of shares.

Summary

• Richard S. Geary, an executive at Ionis Pharmaceuticals, reported transactions involving the company's common stock.
• On January 30, 2025, Geary acquired 3,820 shares due to the vesting of performance-based restricted stock units (PRSUs) at a price of $0.0.
• These PRSUs vested because the Compensation Committee certified that the company achieved a pre-established performance goal related to relative total shareholder return, resulting in a vest of 150% of target shares.
• On January 31, 2025, Geary sold 1,406 shares at a weighted average price of $32.4049.
• Following these transactions, Geary directly owns 99,077 shares of Ionis Pharmaceuticals.
• The sales occurred at prices ranging from $32.05 to $32.61.

Sentiment

Score: 5

Explanation: The document reflects routine executive stock transactions related to compensation and personal financial planning, with no indication of unusual or concerning activity.

Positives

• The vesting of PRSUs indicates that Ionis Pharmaceuticals achieved a pre-established performance goal related to total shareholder return.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. They can be driven by various factors, including compensation structures, personal financial planning, and company performance. Monitoring these transactions can provide insights into executive sentiment and potential future actions.

Comparison to Industry Standards

• Executive compensation packages often include performance-based equity awards like PRSUs to align management's interests with those of shareholders.
• The vesting of PRSUs based on relative total shareholder return is a common practice to incentivize outperformance compared to peers.
• Executive stock sales are generally viewed in the context of overall holdings and trading patterns to assess potential implications.

Key Dates